Status:
COMPLETED
Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin
Lead Sponsor:
Medical Research Foundation, The Netherlands
Collaborating Sponsors:
Langerhans Foundation, the Netherlands
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Self-monitoring of blood glucose (SMBG) is one of the important instruments in diabetes management. Most patients with type 1 diabetes and patients with type 2 using insulin, frequently measure their ...
Detailed Description
Study Objectives: Primary: What is the effect of SMBG in patients with type 2 diabetes who are not using insulin on Glycemic control (as measured with glycosylated hemoglobin (HbA1c)? Secondary: Wha...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Type 2 diabetes
- HbA1c 7 - 8,5% at previous and present annual check-up
- Use of 1 or 2 different oral blood glucose lowering drugs
- In case of two oral blood glucose lowering drugs, they should not both have a maximum dosage
- Sufficient knowledge of the Dutch language to understand the requirements for the study
- Exclusion criteria:
- Change in oral blood glucose lowering drugs in the past three months
- Use of insulin
- Use of device for self-monitoring of blood glucose at the start of the study, or in the preceding 6 months
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00287807
Start Date
February 1 2006
End Date
October 1 2008
Last Update
September 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isala Clinics
Zwolle, Netherlands, 8000 GM